Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

U

University of Barcelona

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

14

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Evaluation of the Anti-plaque Effect of a Bioflavonoid-based Antiseptic Mouthwash: a Randomized, Double-blind, Controlled, Crossover Clinical Trial

Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression: Engagement, Efficacy, and Predictors of Outcome

Earlier

Sep 5, 2026TrialPeanut Consumption on Cognitive Performance, Weight Management, and Inflammation in Young Adolescents

Sep 3, 2026TrialDental-Oral and Craniofacial Characteristics of Hereditary Spastic Paraplegia: A Preliminary Study

Sep 1, 2026TrialLocal and Systemic Inflammatory Bone Alterations Related to Dental Implant Survival.

Aug 29, 2026TrialEffect of Metallic Micro- and Nanoparticles on the Progression of Peri-Implantitis and Their Interaction With the Microbiota

Aug 20, 2026TrialMulticenter Randomized Clinical Trial Comparing Apical Flap Repositioning Versus Vestibular Mucosa Excision Associated With Free Gingival Grafts for Peri-Implant Keratinized Mucosa Augmentation

Jul 10, 2026TrialPatient-Centered Outcomes Throughout Peri-Implantitis Therapy: A Multicenter Prospective Observational Study

4 more events

Jul 8, 2026TrialThe ITA Model of Integrated Treatment of Eating Disorders

Jul 8, 2026TrialEffects of Brief Immersive Training on the Metacognitive Capacities and Self-knowledge of Young People

Jun 25, 2026TrialEffect of Probe Material (Metallic vs. Plastic) on Peri-implant Probing: a Randomized Clinical Trial.

Jan 14, 2025TrialEffectiveness of a Multidisciplinary Treatment for Patients With Chronic Low Back Pain

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)